GREGORY JULIA P
Insider CIK 1226675 · CFRX CEO · NRIX Director · BHVN Director · BHVN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2026-10-14 | 2026-10-14 | 22,583 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2026-10-14 | 2026-10-14 | 22,583 | $23.40 | $528.5K | 10,750 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2026-10-14 | 2026-10-14 | 22,583 | $1.86 | $42.0K | 33,333 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2026-04-28 | 2026-04-30 | 68,693 | — | $0 | 68,693 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2025-09-17 | 2025-09-17 | 10,750 | — | $0 | 22,583 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2025-09-17 | 2025-09-17 | 10,750 | $1.86 | $20.0K | 10,750 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2025-05-05 | 2025-05-07 | 31,716 | — | $0 | 31,716 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2024-05-20 | 2024-05-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2024-04-30 | 2024-05-02 | 16,592 | — | $0 | 16,592 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2023-05-04 | 2023-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2023-05-02 | 2023-05-04 | 52,906 | — | $0 | 52,906 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-25 | 2022-10-26 | 9,523 | $10.50 | $100.0K | 25,665 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 8,239 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 11,996 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 18,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 18,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 9,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 9,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 5,998 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 4,119 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2022-10-03 | 2022-10-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 5,998 | — | $0 | 5,998 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 4,119 | — | $0 | 4,119 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 9,000 | $2.33 | $21.0K | 19,117 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 4,119 | $4.84 | $19.9K | 4,119 | SEC↗ |
| BHVN Biohaven Ltd. | F Tax w/h | 2022-10-03 | 2022-10-05 | 11,975 | $7.50 | $89.8K | 16,142 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 9,000 | $3.06 | $27.5K | 28,117 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 5,998 | $3.56 | $21.4K | 10,117 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2022-05-05 | 2022-05-06 | 17,500 | — | $0 | 17,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-04-28 | 2022-04-29 | 8,239 | — | $0 | 8,239 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-12-20 | 2021-12-22 | 12,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-12-20 | 2021-12-22 | 12,000 | $23.63 | $283.6K | 12,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2021-12-20 | 2021-12-22 | 12,000 | $125.00 | $1.50M | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2021-05-06 | 2021-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-05-05 | 2021-05-07 | 11,996 | — | $0 | 11,996 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2020-04-30 | 2020-05-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-11-22 | 2019-11-22 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-11-22 | 2019-11-22 | 12,000 | $54.75 | $657.0K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-11-22 | 2019-11-22 | 12,000 | $23.63 | $283.6K | 12,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-05-21 | 2019-05-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-02-21 | 2019-02-25 | 12,000 | — | $0 | 24,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-02-21 | 2019-02-25 | 12,000 | $23.63 | $283.6K | 12,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-02-21 | 2019-02-25 | 12,000 | $43.56 | $522.7K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2018-05-01 | 2018-05-03 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-08-02 | 2017-08-04 | 36,000 | — | $0 | 36,000 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy | 2015-03-02 | 2015-03-03 | 11,778 | $4.61 | $54.3K | 50,283 | SEC↗ |
| CFRX CONTRAFECT Corp | A Award | 2014-09-11 | 2014-10-08 | 29,946 | $4.00 | $119.8K | 38,505 | SEC↗ |